View Document Preview and Link Document Date: 2015-05-27 10:15:21 Open Document File Size: 241,75 KB Share Result on Facebook
City Philadelphia / London / San Diego / / Company Celgene Corporation / V Mouse Group CKD-3 V Mouse Group / Kentucky Nephrology Research Trust / Circulation BV / 3Celgene Corporation / K DIGO CKD-MBD Work Group / / Country United States / United Kingdom / / Facility University of Kentucky / 2Washington University / / IndustryTerm treatment of chronic kidney disease / / MedicalCondition Despite hyperparathyroidism / hyperphosphatemia / diabetes / hyperlipidemia / bone disease / chronic kidney disease / disorder / bone resorption / adynamic bone disease / Renal Osteodystrophy / anemia / hypercholesterolemia / syndrome / end-stage kidney disease / / MedicalTreatment hemodialysis / / Organization Congress / US Federal Reserve / Akel NS / University of Kentucky / 2Washington University / St. Louis / / Person Marie-Claude Monier-Faugere / William T. Smith / Keith A. Hruska / Victoria Sung / Hartmut Malluche / / Position Miner / / ProvinceOrState Kentucky / Nova Scotia / / Technology pharmacokinetics / PDF / / SocialTag 
The Role of Activin Signaling in the Pathogenesis of Renal Osteodystrophy of CKD-MBD FP406 Hartmut Malluche ; Marie-Claude Monier-Faugere ; Toshifumi Sugatani ; Yifu Fang ;